MarketCap
Facebook
X
TelegramQuidel Corporation Cash Conversion Cycle 2011-2026 | QDEL
Annual Cash Conversion Cycle Quidel Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 68.4 | 417 | 453 | 513 | 657 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 657 | 68.4 | 422 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 202.23 | -0.41 % | $ 22.4 B | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
51.8 | $ 18.71 | 0.16 % | $ 576 M | USA |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 3.88 | -9.56 % | $ 5.16 M | USA |
 |
Castle Biosciences
CSTL
|
31.6 | $ 20.58 | -0.58 % | $ 597 M | USA |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
2.11 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
79.6 | $ 130.26 | -1.03 % | $ 16.3 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 24.1 | 4.92 % | $ 1.28 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 1.64 | 2.19 % | $ 7.26 M | USA |
 |
Illumina
ILMN
|
147 | $ 164.64 | 2.28 % | $ 25.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
52.5 | $ 147.28 | 0.75 % | $ 11.6 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 104.72 | 0.19 % | $ 7.07 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 190.02 | 1.34 % | $ 9.42 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 465.86 | -0.32 % | $ 13.4 B | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 152.77 | 1.88 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 11.11 | -0.36 % | $ 1.42 B | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 18.29 | -2.69 % | $ 409 M | USA |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.33 | -0.12 % | $ 401 M | USA |
 |
Natera
NTRA
|
48.3 | $ 214.63 | 1.2 % | $ 29.3 B | USA |
 |
Pacific Biosciences of California
PACB
|
185 | $ 1.35 | 2.67 % | $ 405 M | USA |
 |
Personalis
PSNL
|
-1.89 | $ 10.05 | 4.8 % | $ 897 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 26.73 | 1.02 % | $ 25.3 B |  Niderland |
 |
Senseonics Holdings
SENS
|
36.1 | $ 7.27 | 1.25 % | $ 303 M | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
-398 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
172 | $ 2.01 | -1.95 % | $ 4.62 M | USA |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 82.74 | 8.62 % | $ 4.95 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 264.65 | -0.57 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 473.92 | 1.08 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.68 | 3.86 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
150 | $ 9.3 | 2.14 % | $ 2.02 B | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |